MITA Says New Analysis Confirms the Value of Low-Dose Lung CT for High-Risk Medicare Beneficiaries


The Medical Imaging & Technology Alliance (MITA) today said a new analysis published in the Annals of Internal Medicine confirms the value of low-dose computed tomography (LDCT) lung imaging for high-risk Medicare-eligible patients. “These findings provide even more direct evidence of the benefits of low-dose CT imaging for detecting lung cancer in Medicare beneficiaries at high risk for this deadly disease,” said Gail Rodriguez, executive director of MITA.


Click here for the full article.